These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23136396)

  • 1. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.
    Hick A; Wattenhofer-Donzé M; Chintawar S; Tropel P; Simard JP; Vaucamps N; Gall D; Lambot L; André C; Reutenauer L; Rai M; Teletin M; Messaddeq N; Schiffmann SN; Viville S; Pearson CE; Pandolfo M; Puccio H
    Dis Model Mech; 2013 May; 6(3):608-21. PubMed ID: 23136396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes.
    Li J; Rozwadowska N; Clark A; Fil D; Napierala JS; Napierala M
    Stem Cell Res; 2019 Oct; 40():101529. PubMed ID: 31446150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Ku S; Puckett JW; Dervan PB; Gottesfeld JM
    J Biol Chem; 2012 Aug; 287(35):29861-72. PubMed ID: 22798143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.
    Crombie DE; Curl CL; Raaijmakers AJ; Sivakumaran P; Kulkarni T; Wong RC; Minami I; Evans-Galea MV; Lim SY; Delbridge L; Corben LA; Dottori M; Nakatsuji N; Trounce IA; Hewitt AW; Delatycki MB; Pera MF; Pébay A
    Aging (Albany NY); 2017 May; 9(5):1440-1452. PubMed ID: 28562313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes.
    Angulo MB; Bertalovitz A; Argenziano MA; Yang J; Patel A; Zesiewicz T; McDonald TV
    Mol Genet Genomic Med; 2023 Jan; 11(1):e2093. PubMed ID: 36369844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.
    Lee YK; Ho PW; Schick R; Lau YM; Lai WH; Zhou T; Li Y; Ng KM; Ho SL; Esteban MA; Binah O; Tse HF; Siu CW
    Pflugers Arch; 2014 Sep; 466(9):1831-44. PubMed ID: 24327207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich's Ataxia.
    Lai Y; Diaz N; Armbrister R; Agoulnik I; Liu Y
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
    Polak U; Li Y; Butler JS; Napierala M
    Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A).
    Ahmad I; Kamai A; Zahra S; Kapoor H; Kumar Srivastava A; Faruq M
    Stem Cell Res; 2024 Jun; 77():103382. PubMed ID: 38484450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons.
    Mishra P; Sivakumar A; Johnson A; Pernaci C; Warden AS; El-Hachem LR; Hansen E; Badell-Grau RA; Khare V; Ramirez G; Gillette S; Solis AB; Guo P; Coufal N; Cherqui S
    Front Pharmacol; 2024; 15():1323491. PubMed ID: 38420191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient.
    Bolotta A; Abruzzo PM; Baldassarro VA; Ghezzo A; Scotlandi K; Marini M; Zucchini C
    Oxid Med Cell Longev; 2019; 2019():7623023. PubMed ID: 31049138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
    Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability.
    Ku S; Soragni E; Campau E; Thomas EA; Altun G; Laurent LC; Loring JF; Napierala M; Gottesfeld JM
    Cell Stem Cell; 2010 Nov; 7(5):631-7. PubMed ID: 21040903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich's ataxia (FRDA) patients with pathogenic (GAA/TTC)n repeat expansion in first intron of the Frataxin (FXN) gene.
    Ahmad I; Kapoor H; Kumar Srivastava A; Faruq M
    Stem Cell Res; 2024 Feb; 74():103289. PubMed ID: 38141359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.